Nutritional compositions containing synergistic combination and uses thereof
US-2015037455-A1 · Feb 5, 2015 · US
US10945446B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10945446-B2 |
| Application number | US-202016776777-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 30, 2020 |
| Priority date | Jul 10, 2015 |
| Publication date | Mar 16, 2021 |
| Grant date | Mar 16, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for enhancing cognitive development in a pediatric subject involving administering to the subject a nutritional composition which includes up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein or protein equivalent source; 0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and 0.015 g/100 Kcal to 1.5 g/100 Kcal of a prebiotic.
Opening claim text (preview).
What is claimed is: 1. A nutritional composition comprising: up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein source; 0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk, wherein the buttermilk comprises 6 mg/100 Kcal to 300 mg/100 Kcal of phospholipids, 1 mg/100 Kcal to 60 mg/100 Kcal of sphingomyelin, and 0.25 mg/100 Kcal to 7.5 mg/100 Kcal of gangliosides; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acids; and a prebiotic. 2. The nutritional composition of claim 1 , wherein the buttermilk is present at a level of about 0.6 g/100 Kcal to about 15 g/100 Kcal. 3. The nutritional composition of claim 1 , wherein the source of long chain polyunsaturated fatty acids comprises docosahexaenoic acid. 4. The nutritional composition of claim 3 , wherein the source of long chain polyunsaturated fatty acids further comprises arachidonic acid. 5. The nutritional composition of claim 4 , wherein the source of long chain polyunsaturated fatty acids is present at a level of about 5 mg/100 Kcal to about 75 mg/100 Kcal. 6. The nutritional composition of claim 5 , wherein the source of long chain polyunsaturated fatty acids comprises docosahexaenoic acid and arachidonic acid at a ratio of arachidonic acid to docosahexaenoic acid of about 1:3 to about 9:1. 7. The nutritional composition of claim 1 , wherein the prebiotic is present at a level of about 0.015 g/100 Kcal to about 1.5 g/100 Kcal. 8. The nutritional composition of claim 1 , wherein the prebiotic comprises polydextrose and galactooligosaccharides. 9. The nutritional composition of claim 7 , wherein the polydextrose and galactooligosaccharides comprise at least about 20% of the prebiotic composition. 10. The nutritional composition of claim 1 , wherein the nutritional composition is an infant formula. 11. A nutritional composition comprising: up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein source; 0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk, wherein the buttermilk comprises 6 mg/100 Kcal to 300 mg/100 Kcal of phospholipids, 1 mg/100 Kcal to 60 mg/100 Kcal of sphingomyelin, and 0.25 mg/100 Kcal to 7.5 mg/100 Kcal of gangliosides; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acids; a prebiotic; and lactoferrin. 12. The nutritional composition of claim 11 , wherein the buttermilk is present at a level of 0.6 g/100 Kcal to 15 g/100 Kcal. 13. The nutritional composition of claim 11 , wherein the lactoferrin is present at a level of about 5 mg/100 Kcal to about 300 mg/100 Kcal. 14. The nutritional composition of claim 13 , wherein the lactoferrin is from a non-human source. 15. The nutritional composition of claim 11 , wherein the source of long chain polyunsaturated fatty acids comprises docosahexaenoic acid, arachidonic acid, or a combination thereof. 16. The nutritional composition of claim 15 , wherein the source of long chain polyunsaturated fatty acids is present at a level of about 5 mg/100 Kcal to about 75 mg/100 Kcal. 17. The nutritional composition of claim 16 , wherein the source of long chain polyunsaturated fatty acids comprises docosahexaenoic acid and arachidonic acid at a ratio of arachidonic acid to docosahexaenoic acid of about 1:3 to about 9:1. 18. The nutritional composition of claim 11 , wherein the prebiotic is present at a level of about 0.015 g/100 Kcal to 1.5 g/100 Kcal. 19. The nutritional composition of claim 11 , wherein the prebiotic comprises polydextrose and galactooligosaccharides. 20. The nutritional composition of claim 11 , wherein the nutritional composition is an infant formula.
Serine endopeptidases (3.4.21) · CPC title
Dairy proteins · CPC title
Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12 · CPC title
using additives (addition of substantially indigestible substances A23L33/21) · CPC title
Addition of substantially indigestible substances, e.g. dietary fibres · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.